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1251-[TyrJ]scy11atoxin allowed to label a single class of high-affinity receptors in membranes from the human neuroblastoma cell line N&-OK I. 
The & of these receptors was 60 pM for scyllatoxin (Leiurotoxin I) and 20 pM’ for apamin and the O,,, was low (3.8 fmol/mg membrane protein). 
K+ increased toxin binding at low concentrations but exerted opposite effects at high concentrations. Ca2+, guanidinium and Nat exerted only 
inhibitory effects on binding. Scylla:oxin binding sites were overexpresscd 2.5-fold after a 24-h cell pretreatment with 2 mM butyrate. This effect 
was suppressed by cycloheximide. 
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1. INTRODUCTION 
Apamin, a neurotoxin from bee venom, is a highly 
basic octadecapeptide that binds with high affinity to a 
protein present in low abundance in membranes from 
the central nervous system, skeletal, cardiac and 
smooth muscles, and hepatocytes, thereby blocking SK 
‘small’ Cazc-activated K+ channels [l-6]. Apamin- 
sensitive SK channels have a low conductance 
(5-20 pS) and are responsible for the pro’Ionged after- 
hyperpolarization that follows Na- and/or Ca- 
dependent action potentials in nerve and muscle cells 
[7,8]. Scyllatoxin (Eeiurotoxin I), a 3i-aminu-a& Gci;- 
tide from t’he venom of the scorpion Leiuvus quin- 
questriatus heOraeus is also a blocker of these channels. 
Despite the fact that scyllatoxin shares no obvious se- 
quence homology with apamin (apart from high basici- 
ty and sulfur content and a C-terminal amidated His 
residue: Table I), it inhibits apamin binding to its recep- 
tors, alters smooth muscle contraction, and blocks 
apamin-sensitive SK channels in guinea pig hepatocytes 
[9-121. We report here the characterization of 
scyllatoxin binding sites in the human neuroblastoma 
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cell line NB-OK 1 and the overexpression of these bin- 
ding sites in the presence of butyrate. 
2. MATERIALS AND METHODS 
2. I . Cell culture and membrane m-emvation 
The NB-OK I cells were cultured in RPM 1 1640 medium enriched 
with 10% foetal calf serum, 100 U/ml penicillin, 100 &ml strep- 
tomycin and 2 mM L-glutamine. At confluence, the cells were sub- 
cultured using a trypsin-EDTA solution for detaching cells. In cast of 
cell pretreatment, the culture medium of preconfluent cells was 
renewed with fresh medium supplemented with the drug to be tested. 
At confluence, the cells were dislodged with a rubber policeman, cen- 
trifuged for 5 min at 100 x g, rinsed with fresh culture medium, lyted 
in I mM NaHC03 and quickly frozen in liquid Nz. The lysate was 
defrosted and centrifuged at 4°C for IO min at 100 x gr The resulting 
supernatant was centrifuged at 20000 x g for 20 min at 4°C. This 
crude membrane pellet was re-homogenized in 50 mM Tris-HCI, pH 
8.0, containing 2 mM KCI, 2 mM EDTA and 0.5% bovine serum 
albumin. 
2.2. Radioiodination and pur$cation of ‘zSI-[TyrZ/scyllaroxinJscyllatoxin 
WC used a synthetic scyllatoxin analogue with a Tyr residue in posi- 
tion 2 (to permit iodination on that residue rather than on His”) with 
binding properties similar to those of scyllato!iin [IO], [Tyr’]scyllatox- 
in (I5 pg = 4.5 nmol) was incubated with IODO-GEN (2 yg = 
4.5 nmol) and NalZ’I (2 mCi = 1 nmol) in 100~1 of 200 mM 
potassium phosphate buffer, pH 7.4. After 15 min at room 
temperature, the reaction mixture was transferred, adjusted to I ml 
with 0.1% TFA-5% CHJCN and loaded into a PBondapak CIS col- 
umn (3.9 x 300 mm) equipped with a guard column equilibrated with 
0.1% TFA-5% CH3CN. The column was eluted (in 60 min) with a 
linear gradient of CH3CN (S-32%) in 0.1% TFA. HPLC was 
monitored at 280 nm and radioactivity measured in a gamma counter. 
Fractions of interest were checked for their binding capacity on 
neuroblastoma cell membranes (see below). In this system, ‘2sl- 
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[Tyr2jscyllatoxin eluted with 21% CHJCN in 0.1% TFA (as compared 
to 20% CHrCN for [TyrzJscyllaroxin) and its specific radioactivity 
was 2 mCi/nmol. 
2.3. Binding studies 
The standard incubation medium consisted of 50 mM Tris-HCI, 
pH 8.0, containing 2 mM KCI, 2 mM EDTA. 0.5% bovine serum 
albumin, the indicated unlabelled peptide concentrations, ‘231- 
[Tyrc]scyllatoxin and 150 zg membrane protein in a final volume of 
IZOJ. After incubation at OOC, the reaction was terminated by ad- 
ding 2 ml ice-cold 50 mM sodium phosphate buffer, pH 7.4, followed 
by rapid filtration through glass-fiber filter (GF/C, Whatman, 
Maidstone, UK) presoaked for 24 h in 0.1% poly(ethyleneimine) in 
order to reduce non-specific binding. The filter was then rinsed 3 x 
with 2 ml of the same buffer and the radioactivity measured. Except 
when otherwise indicated, non-specific binding was determined in the 
presence of 1 PM apamin and accounted for approximatively 25% of 
total binding. Specific binding was defined as total binding minus 
non-specific binding and always represented less than 15% of the total 
radioactivity offered. 
2.4. Chemiculs 
Carrier-free Na”sI (IMS300,600-800 mCi/ml) came from Amers- 
ham Corp. (Bucks, UK) and IODO-GEN from Pierce (Oud- 
Beijerland, Netherlands). Foetal calf serum and medium for cell 
cultures were from Cibco Europe (Gent, Belgium). HPLC materials 
were from Waters Associates (Milford, MA). Butyrate and analogues 
were purchased from Sigma Chemical Co. (St. Louis, MO, USA). 
Highly purified natural apamin was from Serva Feinbiochemica 
(Heidelberg, Germany). 
3. RESULTS 
Specific ‘zSI-[Tyr2]scyllatoxin binding to NE&OK 1 
membranes was rapid, reversible and saturable. At 
O°C, an apparent binding equilibrium was attained 
Table I 
Amino acid sequences of (A) scyllatoxin (Leiurotoxin I) from Leirrras qrtinqrtestriulus 
hebraeus and (B) apamin from Apis melliferu 
1 5 10 IS 20 25 30 
A/ A-F-C-N-L-R-M-C-Q-L-S-C-R-S-L-G-L-L-G-K-C-I-G-D-K-C-E-C-V-K-H-NH~ 
I 5 10 15 
B/ C-N-C-K-A-P-E-T-A-L-C-A-R-R-C-Q-Q-W_NNz 
after 20 min (Fig. IA). Tracer bound after 45 min 
dissociated with a f1/2 of 5 min at O’C, as studied by 
isotopic and chemical dilution, i.e. rapidly, considering 
the temperature (Fig. 1B). Saturation curves were ob- 
tained with various concentrations of ‘=I._ 
[Tyr*]scyllatoxin (lo-300 PM) and their Scatchard 
transformation was compatible with the existence of 
one class of high-affinity binding sites (&I of 40 f 
8 PM) with low maximal binding capacity (3.8 f 
0.6 fmol/mg membrane protein) (Fig. 1C). 
Competition curves showed that unlabelled 
[Tyr*]scyllatoxin inhibited tracer binding with an I&, 
of 0.15 r&I, i.e. a Kd of 60 pM, while apamin was 3 
times more potent with a & of 20 pM (Fig. 2). 
As previously described for [‘2SI]apamin binding sites 
[ 13- 151, Kt ions increased ‘251-[Tyr2]scyllatoxin bin- 
ding at low concentration (by a factor of 1.3 at 1 x 
10e3 mM) while higher concentrations fully inhibited 
ligand binding with an I&, at 40 mM (Fig. 3A). Three 
other cations were only inhibitory with ICSO values at 
4 mM for Ca’+, 15 mM for guanidinium, and 60 mM 
for Na+ (Fig. 3B). ATP, ATP S, GTP, GppNHp and 
GTP S, when tested in the 3 * 10-6-3 - lob4 M concen- 
tration range, exerted no effect on tracer binding. 
A 24-h preincubation of NB-OK 1 cells with 2 mM 
butyrate increased 2- to 3-fold the number of scyllatox- 
in receptors and Scatchard plots were compatible with 
a genera1 2-fold increase in Kd or, more likely so, with 
the appearance of a second subpopulation of receptors 
with a 4- to 5-fold lowered affinity (Fig. 4 and see 
Chemical 
dilution 
TIME lminl TIME (min) B(fmol/mg protein) 
Fig. 1. (A) Kinetics of specific ‘*“I-[Ty?]scyllatoxin binding to NB-OK 1 membranes at 0°C (in 010 of equilibrium binding). (B) Dissociation kinetics 
of prehound ‘Z’I-[TyrZ]scyllatoxin at 0°C. After 45 min incubation with tracer at O”C, 1 FM unlahelled [Tyr’]scyllatoxin (0) or IO ml cold 
standard incubation medium (0) was added to induce dissociation. (C) Scatchard representation of a saturation curve of ‘2SI-[Tyr2]scyllatoxin 
binding. Results were the means of experiments performed on three different membrane preparations. 
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Fig. 2. Inhibition of ‘2S1-[TyrZ]scyllatoxin binding to NB-OK 1 
membranes by unlabehed [Tyr’]scyllatoxin (e) and apamin (0). 
Membranes were incubated for 45 min at O°C in the presence of 
60 pM tracer and increasing concentrations of unlabelled peptide. 
The results were expressed in percent of tracer specifically bound in 
the absence of unlabelled peptide and were the means of experiments 
performed in duplicate on three different membrane preparations. 
discussion). The presence of 3.6 PM cycloheximide, 
together with butyrate, prevented this overexpression 
(data not shown). These alterations were reproduced 
very partially with 2 mM 3-hydroxybutyrate but not 
with 2 mM isobutyrate, 1 mM carbamylcholine, 
100 nM 12-0-tetradecanoylphorbol 13-acetate (TPA), 
2 mM 8-bromo-CAMP, or the two latter agents added 
in combination. Under these experimental conditions 
the number and protein content of NB-OK 1 cells were 
not significantly affected after 24 h. 
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Fig. 4. Scatchard representation of ‘2’I-[Tyr2]scyllatoxin binding to 
membranes from control NR-OK 1 cells (0) and cells pretreated with 
2 mM butyrate (A), 2 mM isobutyrate (O), or 2 mM 
3-hydroxybutyrate (0) for 24 h. These results illustrate one 
experiment performed in duplicate that was representative of two 
others. 
scyllatoxin, an analogue where the substitution of Phe 
by Tyr in position 2 does not change the toxin affinity 
for binding sites in rat brain membranes [9]. In the 
present study, a single class of such binding sites 
was characterized in membranes from human neuro- 
blastoma N&OK 1 cells. The Kd of 40 pM was in good 
4. DISCUSSION 
ScyIIatoxin binding sites were identified in human 
neurablastoma N&-OK 1 membranes with 1zsI-[Fyr2]- 
Guanidinium 
IN+3 ilog M) [CATION [log Ml 
Fig. 3. (A) Effects of K’ on ‘2Sl-~Tyr2]scyllatoxin binding to NB-OK 1 membranes. Various KC1 concentrations were added to a standard 
incubation medium (free of KCi). Membranes were incubated for 45 min at 0°C in the presence of 60 pM tracer. (B) Effects of Ca*+, guanidinium 
and Na’ on ‘“51-[Tyrz]scyllatoxin binding to NE-OK 1 membranes. The standard incubation medium (see section 2) was supplemented with various 
concentrations of free Ca”. (a), of guanidinium-I-ICI (0) or of NaCl (A). Membranes were incubated for 45 min at 0°C in the presence of 
120 pM tracer, Results were expressed in percentage of maximal binding measured with a KCI-free medium (panel A) or with the standard 
unsupplemented incubation medium (panel B) and were the means of experiments performed in duplicate on three different membrane 
preparations. 
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agreement with that found for rat brain membranes (& 
8ij pM) [9]. Apamin competitively inhibited ‘is11 
[Tyr’]scylIatoxin binding (Fig. 2). 
As for ‘2SI-[Tyr2]scyllatoxin and [“‘I]apamin bind- 
ing to rat brain membranes, we observed that i2’I- 
[Tyr”]scyllatoxin binding was enhanced at Iow K+ con- 
centration but inhibited at higher K+ concentrations. 
Ca2’, guanidinium and Naf were only inhibitory. This 
variety of cationic effects has been explained previously 
in terms of two sites: (a) an allosteric stimulatory KC 
(and Rb+) specific site, and (b) a second, inhibitory 
anionic site, which binds the cationic groups of 
scyllatoxin and apamin [14,16]. 
Apamin receptors are present in very small amounts 
(I-30 fmol/mg protein) in all celi types and excitable 
membranes investigated until now (for references see 
[17]). For example, there are 125 times more 
tetrodotoxin binding sites than apamin binding sites in 
synaptosomal membranes [14]. Higher levels of 
[‘2sI]apamin binding sites (600 fmol/mg protein) have 
been reported in the undifferentiated rat pheochromo- 
cytoma cell line PC 12 but, when treated with nerve 
growth factor, these cells differentiate into a more 
neuronal-like type and show a reduced number of 
apamin receptors [17]. 
Due to the very low density of scyllatoxin binding 
sites in the present human neurobiastoma cell line NB- 
OK I, and to the usual contribution of SK channels to 
membrane repolarization, it is of interest to note that 
our cell line is endowed with muscarinic Mi receptors 
that are susceptible to stimulate PIP2 hydrolysis and 
Ca2+ movements ([ 181 and data not shown). 
Butyrate produces pleiotropic effects on cells in 
culture that are often associated with histone 
hyperacetylation and gene transcription (for review see 
[19-221). In the present case, butyrate provoked a 
cycloheximide-inhibited overexpression of scyllatoxin 
receptors with an affinity likely to be somewhat reduced 
as compared to control receptors (Fig. 4). Isobutyrate, 
which has also been reported to inhibit histone 
deacetylase [22], did not increase the number of 
scyllatoxin receptors but this might be due to distinct 
NB-OK 1 cell permeability to short chain fatty acids or 
to their distinct intracelluIar metabolism. The present 
data show the interest to elucidate the possible role of 
scyllatoxin binding sites (SK channels) as regulators of 
proliferation, differentiation and biological activation 
in this neuronal cell line. 
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